| __timestamp | Alkermes plc | Alnylam Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 618789000 | 50561000 |
| Thursday, January 1, 2015 | 628335000 | 41097000 |
| Friday, January 1, 2016 | 745694000 | 47159000 |
| Sunday, January 1, 2017 | 903374000 | 89912000 |
| Monday, January 1, 2018 | 1094274000 | 74908000 |
| Tuesday, January 1, 2019 | 1170947000 | 219750000 |
| Wednesday, January 1, 2020 | 1038756000 | 492853000 |
| Friday, January 1, 2021 | 1173751000 | 844287000 |
| Saturday, January 1, 2022 | 1111795000 | 1037418000 |
| Sunday, January 1, 2023 | 1663405000 | 1828292000 |
| Monday, January 1, 2024 | 1557632000 | 2248243000 |
Unlocking the unknown
In the dynamic world of biotechnology, revenue trends offer a window into a company's growth and market position. Alnylam Pharmaceuticals, Inc. and Alkermes plc, two prominent players in the industry, have shown distinct revenue trajectories over the past decade. From 2014 to 2023, Alkermes plc experienced a steady revenue increase, peaking at approximately $1.66 billion in 2023, marking a growth of over 168% from its 2014 revenue. Meanwhile, Alnylam Pharmaceuticals, Inc. demonstrated a remarkable surge, with its revenue skyrocketing from a modest $50 million in 2014 to an impressive $1.83 billion in 2023, reflecting a staggering growth of over 3,500%. This data underscores Alnylam's rapid expansion and increasing market influence, while Alkermes maintains a stable growth trajectory. These trends highlight the evolving landscape of the biotech sector, driven by innovation and strategic advancements.
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Perrigo Company plc
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Revenue Insights: Alnylam Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?
Biogen Inc. vs Alkermes plc: Annual Revenue Growth Compared
Revenue Showdown: Cytokinetics, Incorporated vs Alkermes plc
Revenue Insights: Alkermes plc and Perrigo Company plc Performance Compared
Alkermes plc or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?